FDU-PB-22

FDU-PB-22 is a derivative of JWH-018 that is presumed to be a potent agonist of the CB1 receptor, and has been sold online as a designer drug.

Pharmacology
FDU-PB-22 acts as a full agonist with a binding affinity of 1.19nM at CB1 and 2.43nM at CB2 cannabinoid receptors.

Legal status
FDU-PB-22 is a controlled substance in Germany and is banned in Japan and Sweden.